You have 5 free searches left this month | for more free features.

keratinocyte

Showing 1 - 25 of 211

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Keratinocyte Skin Cancer Trial in Wuppertal (Nevisense)

Recruiting
  • Keratinocyte Skin Cancer
  • Nevisense
  • Wuppertal, Germany
    CentroDerm
Sep 28, 2023

Alopecia, Chemo-Induced Change, Hair Loss Trial in Tucson (Keratinocyte growth factor)

Completed
  • Alopecia
  • +3 more
  • Keratinocyte growth factor
  • Tucson, Arizona
    University of Arizona
Dec 15, 2022

HRQoL Keratinocyte Carcinomas

Enrolling by invitation
  • Basal Cell Carcinoma
  • +2 more
  • questionnaires
  • Ghent, Belgium
  • +1 more
Jan 25, 2023

Burn Degree Second, Burn Degree Third Trial in Jakarta Pusat (Split-thickness skin graft, Artificial skin graft, Artificial skin

Recruiting
  • Burn Degree Second
  • Burn Degree Third
  • Split-thickness skin graft
  • +2 more
  • Jakarta Pusat, DKI Jakarta, Indonesia
    RSUPN Cipto Mangunkusumo
Dec 8, 2022

Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)

Not yet recruiting
  • Non-melanoma Skin Cancer
  • +3 more
  • Calgary, Alberta, Canada
  • +7 more
Jul 13, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Jan 12, 2023

Vitiligo Trial in Irvine (MKTP with Surgical blade, MKTP with Negative Pressure Instrument, Suction blister grafting without

Recruiting
  • Vitiligo
  • MKTP with Surgical blade
  • +2 more
  • Irvine, California
    University of California, Irvine
Jun 16, 2021

Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Toronto (Nicotinamide, Placebo oral capsule)

Active, not recruiting
  • Non-melanoma Skin Cancer
  • +2 more
  • Toronto, Ontario, Canada
    Toronto General Hospital, University Health Network
Feb 9, 2022

Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

Recruiting
  • Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022

Keratinocyte Carcinoma Trial in Cleveland (SOC education, Ask-tell-ask education, Participant satisfaction survey)

Recruiting
  • Keratinocyte Carcinoma
  • SOC education
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 7, 2021

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa Trial in Redwood City, Worcester (EB-101)

Active, not recruiting
  • Epidermolysis Bullosa
  • Recessive Dystrophic Epidermolysis Bullosa
  • EB-101
  • Redwood City, California
  • +1 more
Apr 5, 2022

Multiple Sclerosis Trial in Cambridge (Palifermin, Alemtuzumab)

Terminated
  • Multiple Sclerosis
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Apr 26, 2019

Solid Organ Transplant Recipients, Skin Cancer Trial in Australia (Sirolimus Topical Cream, Placebo)

Not yet recruiting
  • Solid Organ Transplant Recipients
  • Skin Cancer
  • Sirolimus Topical Cream
  • Placebo
  • Camperdown, New South Wales, Australia
  • +5 more
May 8, 2023

Participants Previously Treated With EB-101 for Treatment of

Enrolling by invitation
  • RDEB
  • EB-101
  • Redwood City, California
  • +1 more
Feb 1, 2023

Lichen Planus Trial in Besançon, Paris, Reims (Human biological samples)

Completed
  • Lichen Planus
  • Human biological samples
  • Besançon, France
  • +2 more
Feb 14, 2022

Scalp Psoriasis Trial in Karachi (Tazarotene 0.045% Topical Application Lotion [ARAZLO])

Completed
  • Scalp Psoriasis
  • Tazarotene 0.045% Topical Application Lotion [ARAZLO]
  • Karachi, Sindh, Pakistan
    JPMC
Aug 28, 2023

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

Not yet recruiting
  • Epidermolysis Bullosa
  • +2 more
  • EB-101 Surgical application of RDEB wounds
  • Redwood City, California
  • +1 more
Feb 13, 2023

Hyper-Immunoglobulin E. Syndrome (HEIS), Chronic Granulomatous Disease (CGD) Trial run by the National Institute of Allergy and

Not yet recruiting
  • Hyper-Immunoglobulin E. Syndrome (HEIS)
  • Chronic Granulomatous Disease (CGD)
  • Blister induction
  • Skin Biopsies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Acne Vulgaris Trial in Qina (Isotretinoin, ELISA Assays of Serum TWEAK.)

Completed
  • Acne Vulgaris
  • Qinā, Qena, Egypt
    South Valley University
Jan 5, 2023

Skin Health Trial in Gainesville (Cranberry juice, Placebo juice)

Recruiting
  • Skin Health
  • Cranberry juice
  • Placebo juice
  • Gainesville, Florida
    Food Science and human nutrition department at University of Flo
Sep 15, 2022

Vitiligo, Generalized Trial (surgical treatment of vitiligo using NCES)

Not yet recruiting
  • Vitiligo, Generalized
  • surgical treatment of vitiligo using NCES
  • (no location specified)
Aug 15, 2022

Grover's Disease, Psoriasis Vulgaris Trial in Chicago (Blue light phototherapy)

Recruiting
  • Grover's Disease
  • Psoriasis Vulgaris
  • Blue light phototherapy
  • Chicago, Illinois
    Knute Martell
Jun 8, 2022

Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,

Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
  • +1 more
Aug 20, 2022

Oral Mucositis Trial in Van (Hyaluronic acid, Sodium bicarbonate)

Completed
  • Oral Mucositis
  • Hyaluronic acid
  • Sodium bicarbonate
  • Van, Turkey
    Yuzuncu Yil University
Apr 5, 2023

Psoriasis Vulgaris, Fractional CO2 Laser Trial in Assiut (Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone

Completed
  • Psoriasis Vulgaris
  • Fractional CO2 Laser
  • Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm
  • Fractional carbon dioxide (CO2) laser
  • Assiut, Egypt
    Assiut University
Aug 23, 2023